Brean Murray Carret & Co. Starts Express Inc. (EXPR) at Buy, Sees Q2 and FY12 Guidance Conservative
Tweet
Share
E-mailGet Alerts EXPR Hot Sheet
Price: $0.83 --0%
Rating Summary:
7 Buy, 9 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
7 Buy, 9 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Brean Murray Carret & Co. initiates coverage on shares of Express Inc. (NYSE: EXPR) with a Buy rating and $26 price target.
The firm believes that EXPR's fashion right focus and ability to react to trend changes quickly will all it to keep strong growing margins. It also fells that the company has material unit and top-line growth potential that will allow it to further leverage its expenses.
Brean Murray Carret urges investors to take advantage of the current share price as it believes that managements guidance for Q2 and FY12 is conservative. The firm calls it the best play in its segment.
The firms FY12 and FY13 EPS estimates are $1.59 and $1.85.
For more ratings news on Express Inc. click here and for the rating history of Express Inc. click here.
Shares of Express Inc. closed at $20.55 yesterday.
The firm believes that EXPR's fashion right focus and ability to react to trend changes quickly will all it to keep strong growing margins. It also fells that the company has material unit and top-line growth potential that will allow it to further leverage its expenses.
Brean Murray Carret urges investors to take advantage of the current share price as it believes that managements guidance for Q2 and FY12 is conservative. The firm calls it the best play in its segment.
The firms FY12 and FY13 EPS estimates are $1.59 and $1.85.
For more ratings news on Express Inc. click here and for the rating history of Express Inc. click here.
Shares of Express Inc. closed at $20.55 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
- H.C. Wainwright Starts ImageneBio (IMA) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Brean Murray Carret & Co.Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
